Understanding anxiety, depression, and bipolar disorder over time in China
Official title: A Prospective Cohort Study of Emotion-Related Disorders
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07903246 · Data updated 2026-11-12
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years to 55 Years |
| Sex | All |
| Enrollment | 2690 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | September 15, 2026 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT07903246 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 12–55 with diagnosed anxiety disorders, depressive disorders, or bipolar disorder, plus healthy controls for comparison, across participating Chinese centers.
✕Probably not a fit
Patients without regular follow-up or those outside the age range or diagnostic groups may have limited benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter prospective cohort study collects clinical, biological, imaging, EEG, wearable, and digital data from participants with anxiety disorders, depressive disorders, bipolar disorder, and healthy controls. It aims to build a standardized research database and develop models that relate symptoms with biomarkers and digital measurements. The study uses longitudinal assessments at baseline and multiple follow-ups over 36 months, plus multi-omics and neuroimaging analyses to explore disease trajectories and prediction across centers. Enrollment is in two cohorts (development and independent validation) totaling approximately 2,690 participants, with careful data integration across sites.
Why it matters
Potential benefit: If successful, the study could improve early recognition and prediction of symptom changes, supporting personalized monitoring and treatment planning.
How similar studies have gone: Previous studies have shown value in multi-modal data for psychiatric research, and this design builds on that approach with a larger, standardized, longitudinal framework.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: General criteria for all groups: * Age 12 to 55 years, inclusive, of any sex. * Education at or above the third-grade primary school level. * Voluntary participation with written informed consent. For participants younger than 18 years, written informed consent from a legal guardian and the participant's assent, when capable, are required. For participants with impaired consent capacity, consent will be obtained from the participant and/or legal guardian as specified in the protocol. Anxiety disorders group: * Meet DSM-5 diagnostic criteria for one or more anxiety spectrum disorders. * Hamilton Anxiety Rating Scale (HAMA-14) total score of at least 14. * Normal intellectual functioning, vision, and hearing. Depressive disorders group: * Meet DSM-5 diagnostic criteria for one or more depressive disorders. * Hamilton Depression Rating Scale (HAMD-17) total score of at least 17. * Normal intellectual functioning, vision, and hearing. Bipolar disorder group: * Meet DSM-5 diagnostic criteria for bipolar I or bipolar II disorder. * Not currently experiencing a manic episode. * Normal intellectual functioning, vision, and hearing. Healthy control group: * Normal or corrected-to-normal vision. * Good physical health, without serious physical illness or chronic disease. * Normal cognitive functioning. * No family history of mental illness across three generations on either the maternal or paternal side. Exclusion Criteria: * The following criteria apply to all groups: * Failure to meet the inclusion criteria for the relevant group, or meeting DSM-5 criteria for a mental disorder other than those targeted by this study. * Current risk of dangerous behavior, rated as level 2 or above on the dangerousness assessment specified in the protocol. * Severe agitation, oppositional behavior, or markedly reduced volition or activity that prevents completion of the assessments. * Current or previous organic brain disease, a history of epilepsy, or a history of traumatic brain injury. * A history of drug or substance abuse, including tobacco, alcohol, or other psychoactive substances. * Cardiovascular, cerebrovascular, respiratory, or neurological disease; infectious disease; other serious physical illness; or a pathological condition that may cause cognitive impairment. * Limb disability or inability to make the required button-press responses using the upper limbs. * Pregnancy or breastfeeding. * Electroconvulsive therapy, transcranial magnetic stimulation, alternating-current or direct-current electrical stimulation, vagus nerve stimulation, or deep brain stimulation within the previous 6 months. * Metal implants or other metallic objects that cannot be safely removed and prevent safe magnetic resonance imaging. * Red-green color blindness. * Any other condition that, in the investigator's judgment, makes participation unsuitable.
Where it's running
-
The Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Ming Zheng, PhD
- Email: mingzheng17@hotmail.com
- Phone: +8619550211701
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
Digital stepped-care mindfulness program for emotional disorders
This project tests whether adding an online mindfulness program to usual care helps adults (18–65) with depression, anxiety, OCD, or PTSD recover faster and stay well longer.
-
Mapping complex cognitive problems across psychiatric and neurological conditions
This project will test a set of cognitive tests and optional brain recordings in adults with psychiatric or neurological disorders and healthy volunteers to map high-level thinking problems and how they change over time.
-
Comparing brief psychoanalytic and emotionally focused couple therapies for relationship distress
This trial will test whether brief psychoanalytic couple therapy or emotionally focused therapy better reduces relationship problems and related depression and anxiety in heterosexual couples with moderate to severe relationship distress.
-
Comparing Islamic and Standard Hypnotherapy for Anxiety and Depression
This study is testing whether a special type of hypnotherapy that incorporates Islamic principles can help Muslim adults with anxiety and depression feel better compared to standard hypnotherapy.
-
Internet-based treatment for anxiety and depression in adolescents
This study is testing an online treatment for anxiety and depression in Romanian teenagers aged 13-17 to see if it helps them feel better and to find out which teens are most likely to benefit from it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.